Literature DB >> 31230385

Visceral arterial embolization prior to multivisceral transplantation in recipient with cirrhosis, extensive portomesenteric thrombosis, and hostile abdomen: Performance and outcome analysis.

Ramona Nicolau-Raducu1, Joshua Livingstone1, Jason Salsamendi2, Thiago Beduschi3, Rodrigo Vianna3, Akin Tekin3, Gennaro Selvaggi3, Yehuda Raveh1.   

Abstract

Multivisceral transplant (MVT) for cirrhosis, and portomesenteric vein thrombosis (PVT), is fraught with life-threatening thrombo-hemorrhagic complications. Embolization of native viscera has been attempted in a handful of cases with mixed results. We carried out a comparative analysis of angiographic, intra-operative, and pathological findings in three recipients of MVT who were deemed exceptionally high hemorrhagic risk and therefore underwent preoperative visceral embolization. All recipients were male with cirrhosis, PVT, and a surgical history indicative of diffuse visceral adhesions; status post-liver transplantation (n = 2) and proctocolectomy (n = 1). The first patient had two Amplatzer II embolization plugs placed 2 cm from the origins of celiac and superior mesenteric (SMA) arteries. Distal migration of the celiac plug into gastroduodenal artery (GDA) and ensuing ischemia reperfusion injury, presumably contributed to severe disseminated intravascular coagulation (DIC) and intra-operative mortality. In the other two recipients, distal Gelfoam embolization of the SMA, GDA, and splenic arteries was performed, and although remarkable hemorrhage and coagulopathy occurred, embolization, undoubtedly, facilitated exenteration and improved outcomes. Pathologic examination in these cases confirmed ischemic necrosis of eviscerated bowel. In conclusion, liver-sparing, preoperative distal embolization of native viscera with Gelfoam is beneficial, but entails several pitfalls. It should currently be reserved for MVT recipients who otherwise are at unacceptably high risk.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  embolization; multivisceral transplantation; portal vein thrombosis

Year:  2019        PMID: 31230385     DOI: 10.1111/ctr.13645

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  1 in total

1.  Preemptive VAE-An Important Tool for Managing Blood Loss in MVT Candidates With PMT.

Authors:  Deeplaxmi P Borle; Samuel J Kesseli; Andrew S Barbas; Aparna S Rege; Deepak Vikraman; Ravindra Kadiyala; Charles Y Kim; Tony P Smith; Paul V Suhocki; Debra L Sudan
Journal:  Transplant Direct       Date:  2021-02-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.